Health System Urges Federal Appeals Court to Revive 340B Overcharge Lawsuit Against Major Drugmakers

Adventist Health System/West alleged in a lawsuit that four major drugmakers defrauded the federal government by overcharging for 340B drugs.
A California health system has urged a federal appeals court to reverse a lower court’s decision to dismiss its lawsuit [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

First Drugmaker Sues Missouri Over its 340B Contract Pharmacy Access Law

AbbVie asked a federal district court to declare unconstitutional Missouri's 340B contract pharmacy access law.
Pharmaceutical giant AbbVie yesterday became the first drugmaker to file suit against Missouri’s new law prohibiting 340B contract pharmacy restrictions [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

State Contract Pharmacy Lawsuit Weekly Roundup: Updates in Mississippi, Maryland

Federal district courts in Maryland and Mississippi saw various legal actions related to state 340B contract pharmacy access laws in the past week.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws this summer, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

West Virginia AG, Hospital Groups Fight Novartis’ Lawsuit to Block State 340B Contract Pharmacy Access Law

The West Virginia attorney general and multiple hospital groups pushed back against Novartis' suit against a state 340B contract pharmacy access law.
The West Virginia attorney general and multiple hospital groups recently urged a federal district judge to deny Novartis’ motion to [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

AbbVie, AstraZeneca Sue Minnesota Over Contract Pharmacy Access Law

AbbVie and AstraZeneca filed a pair of lawsuits to block Minnesota's law barring manufacturer 340B contract pharmacy restrictions.
Two major drug manufacturers are suing Minnesota to block a new 340B contract pharmacy access law, which took effect this [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Texas Hospitals Ask Judge to Block HHS’ DSH Calculation Rule That Impacts 340B Eligibility

A group of Texas hospitals urged a federal court to grant their request for a summary judgement—or at minimum preliminary relief—in a case challenging an HHS rule.
A group of Texas hospitals urged a federal court last week to grant their request for a summary judgement—or at [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

340B Coalition Conference Keynote: Program Faces ‘Progress Amid Challenges’

Maureen Testoni, president and CEO of 340B Health, gave a keynote "state of 340B" address July 8 at the 340B Coalition summer conference.
The 340B program faces unprecedented challenges despite a series of states enacting 340B contract pharmacy access laws, the leader of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

AbbVie, AstraZeneca Challenge Kansas’ New Contract Pharmacy Access Law

AbbVie will no longer offer voluntary 340B pricing on any of its orphan-designated drugs to covered entities subject to such exclusions.
Two major drug manufacturers this week sued Kansas in an effort to block the state’s new contract pharmacy access law, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

Federal Judge Denies Drugmakers’ Bids to Block Mississippi’s New 340B Contract Pharmacy Access Law

U.S. District Judge Halil Ozerden denied separate motions from PhRMA and Novartis to block Mississippi’s 340B contract pharmacy access law.
A federal district judge has rejected two drug industry attempts to block Mississippi’s new state law prohibiting drugmaker 340B contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Supreme Court ‘Chevron’ Ruling Increases Pressure on Congress to Act on 340B But Unlikely to Immediately Impact Program Oversight

Hospital groups are urging the Supreme Court to correct what they called HHS' misinterpretation of DSH percentage calculations.
A landmark Supreme Court decision to limit the broad regulatory authority of federal agencies will increase pressure for Congress to [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live